A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone, With Adjunctive Clarithromycin, in the Treatment of Adult Subjects With Community-Acquired Pneumonia
A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone, With Adjunctive Clarithromycin, in the Treatment of Adult Subjects With Community-Acquired Pneumonia
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of Community-Acquired Pneumonia
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of Community-Acquired Pneumonia. Clinical trials for this study is held in many countries
Inclusion Criteria:
Subjects are required to meet the following inclusion criteria:
Exclusion Criteria:
Subjects must NOT meet any of the following exclusion criteria:
Belo Horizonte MG, 30150-221, Brazil
Curitiba-PR, 80810-040, Brazil
Lindenberger, State of Berlin 13125, Germany
Cheras, Kuala Lumpur 05460, Malaysia
Kedah, 05460, Malaysia
Brzesku, 32-800, Poland
Katowice-Ochojec, 40-635, Poland
Saint Brasov, 25-27, Romania
Nitra-Zobor, 948 88, Slovakia
Benomi, 1500, South Africa
Vizcaya, 48960, Spain
Khonkaen, 40002, Thailand
Aviv, 79013, Ukraine